404 related articles for article (PubMed ID: 17327450)
21. Rosiglitazone inhibits expression and secretion of PEDF in adipose tissue and liver of male SD rats via a PPAR-γ independent mechanism.
Yang S; Luo T; Zhou H; Lv Q; Liu L; Zhang W; Gao R; Chen S; Xia W; Luo M; Cheng Q; Li Q
Endocrinology; 2014 Mar; 155(3):941-50. PubMed ID: 24424059
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects.
Rotter V; Nagaev I; Smith U
J Biol Chem; 2003 Nov; 278(46):45777-84. PubMed ID: 12952969
[TBL] [Abstract][Full Text] [Related]
23. Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling.
Shi H; Tzameli I; Bjørbaek C; Flier JS
J Biol Chem; 2004 Aug; 279(33):34733-40. PubMed ID: 15181014
[TBL] [Abstract][Full Text] [Related]
24. β-Carotene accumulation in 3T3-L1 adipocytes inhibits the elevation of reactive oxygen species and the suppression of genes related to insulin sensitivity induced by tumor necrosis factor-α.
Kameji H; Mochizuki K; Miyoshi N; Goda T
Nutrition; 2010; 26(11-12):1151-6. PubMed ID: 20097535
[TBL] [Abstract][Full Text] [Related]
25. Angiopoietin-like 2, a circadian gene, improves type 2 diabetes through potentiation of insulin sensitivity in mice adipocytes.
Kitazawa M; Nagano M; Masumoto KH; Shigeyoshi Y; Natsume T; Hashimoto S
Endocrinology; 2011 Jul; 152(7):2558-67. PubMed ID: 21586562
[TBL] [Abstract][Full Text] [Related]
26. The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo.
Li YY; Wu HS; Tang L; Feng CR; Yu JH; Li Y; Yang YS; Yang B; He QJ
Pharmacol Res; 2007 Oct; 56(4):335-43. PubMed ID: 17889553
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of suppressor of cytokine signaling 3 in adipose tissue causes local but not systemic insulin resistance.
Shi H; Cave B; Inouye K; Bjørbaek C; Flier JS
Diabetes; 2006 Mar; 55(3):699-707. PubMed ID: 16505233
[TBL] [Abstract][Full Text] [Related]
28. Modulation and lack of cross-talk between signal transducer and activator of transcription 5 and Suppressor of cytokine signaling-3 in insulin and growth hormone signaling in 3T3-L1 adipocytes.
Story DJ; Stephens JM
Obesity (Silver Spring); 2006 Aug; 14(8):1303-11. PubMed ID: 16988072
[TBL] [Abstract][Full Text] [Related]
29. Improved insulin sensitivity and adipose tissue dysregulation after short-term treatment with pioglitazone in non-diabetic, insulin-resistant subjects.
Hammarstedt A; Sopasakis VR; Gogg S; Jansson PA; Smith U
Diabetologia; 2005 Jan; 48(1):96-104. PubMed ID: 15624096
[TBL] [Abstract][Full Text] [Related]
30. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
[TBL] [Abstract][Full Text] [Related]
31. Ginsenoside Re reduces insulin resistance through activation of PPAR-γ pathway and inhibition of TNF-α production.
Gao Y; Yang MF; Su YP; Jiang HM; You XJ; Yang YJ; Zhang HL
J Ethnopharmacol; 2013 May; 147(2):509-16. PubMed ID: 23545455
[TBL] [Abstract][Full Text] [Related]
32. Cilostazol ameliorates metabolic abnormalities with suppression of proinflammatory markers in a db/db mouse model of type 2 diabetes via activation of peroxisome proliferator-activated receptor gamma transcription.
Park SY; Shin HK; Lee JH; Kim CD; Lee WS; Rhim BY; Hong KW
J Pharmacol Exp Ther; 2009 May; 329(2):571-9. PubMed ID: 19221061
[TBL] [Abstract][Full Text] [Related]
33. Obese mice lacking inducible nitric oxide synthase are sensitized to the metabolic actions of peroxisome proliferator-activated receptor-gamma agonism.
Dallaire P; Bellmann K; Laplante M; Gélinas S; Centeno-Baez C; Penfornis P; Peyot ML; Latour MG; Lamontagne J; Trujillo ME; Scherer PE; Prentki M; Deshaies Y; Marette A
Diabetes; 2008 Aug; 57(8):1999-2011. PubMed ID: 18458147
[TBL] [Abstract][Full Text] [Related]
34. Subtherapeutic dose of pioglitazone reduces expression of inflammatory adipokines in db/db mice.
Mohapatra J; Sharma M; Singh S; Chatterjee A; Swain P; Balaraman R; Patel PR; Jain MR
Pharmacology; 2009; 84(4):203-10. PubMed ID: 19738399
[TBL] [Abstract][Full Text] [Related]
35. The adipose tissue endocrine mechanism of the prophylactic protective effect of pioglitazone in high-fat diet-induced insulin resistance.
Gong Y; Li J; Li C; Mu Y; Xiao Y; Tian H; Pan C; Liu Y
J Int Med Res; 2012; 40(4):1304-16. PubMed ID: 22971482
[TBL] [Abstract][Full Text] [Related]
36. The effect of sex hormones on peroxisome proliferator-activated receptor gamma expression and activity in mature adipocytes.
Sato H; Sugai H; Kurosaki H; Ishikawa M; Funaki A; Kimura Y; Ueno K
Biol Pharm Bull; 2013; 36(4):564-73. PubMed ID: 23546292
[TBL] [Abstract][Full Text] [Related]
37. Glimepiride enhances intrinsic peroxisome proliferator-activated receptor-gamma activity in 3T3-L1 adipocytes.
Inukai K; Watanabe M; Nakashima Y; Takata N; Isoyama A; Sawa T; Kurihara S; Awata T; Katayama S
Biochem Biophys Res Commun; 2005 Mar; 328(2):484-90. PubMed ID: 15694373
[TBL] [Abstract][Full Text] [Related]
38. c-Jun N-terminal kinase is involved in the suppression of adiponectin expression by TNF-alpha in 3T3-L1 adipocytes.
Kim KY; Kim JK; Jeon JH; Yoon SR; Choi I; Yang Y
Biochem Biophys Res Commun; 2005 Feb; 327(2):460-7. PubMed ID: 15629137
[TBL] [Abstract][Full Text] [Related]
39. Insulin resistance-inducing cytokines differentially regulate SOCS mRNA expression via growth factor- and Jak/Stat-signaling pathways in 3T3-L1 adipocytes.
Fasshauer M; Kralisch S; Klier M; Lossner U; Bluher M; Klein J; Paschke R
J Endocrinol; 2004 Apr; 181(1):129-38. PubMed ID: 15072573
[TBL] [Abstract][Full Text] [Related]
40. The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells.
Serrano-Marco L; Barroso E; El Kochairi I; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M
Diabetologia; 2012 Mar; 55(3):743-51. PubMed ID: 22179221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
